122 related articles for article (PubMed ID: 12711123)
81. A meta-analysis of thoracic radiotherapy for small-cell lung cancer.
Pignon JP; Arriagada R; Ihde DC; Johnson DH; Perry MC; Souhami RL; Brodin O; Joss RA; Kies MS; Lebeau B
N Engl J Med; 1992 Dec; 327(23):1618-24. PubMed ID: 1331787
[TBL] [Abstract][Full Text] [Related]
82. [Assessment the efficacy of postoperative radiotherapy in the patients with non-small cell lung cancer. Retrospective study].
Chmielewska E; Jodkiewicz Z; Karwański M
Pneumonol Alergol Pol; 2012; 80(2):109-19. PubMed ID: 22370979
[TBL] [Abstract][Full Text] [Related]
83. Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.
Wolf M; Pritsch M; Drings P; Hans K; Schroeder M; Flechtner H; Heim M; Hruska D; Mende S; Becker H
J Clin Oncol; 1991 Apr; 9(4):614-24. PubMed ID: 1648598
[TBL] [Abstract][Full Text] [Related]
84. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
[TBL] [Abstract][Full Text] [Related]
85. A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer.
Garst J; Herndon JE; Shafman T; Campagna L; Blackwell S; Padilla K; Bjurstrom T; Andrews C; Maravich-May D; Anderson E; Crawford J
Clin Drug Investig; 2006; 26(5):257-66. PubMed ID: 17163259
[TBL] [Abstract][Full Text] [Related]
86. Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
Miller AA; Herndon JE; Hollis DR; Ellerton J; Langleben A; Richards F; Green MR
J Clin Oncol; 1995 Aug; 13(8):1871-9. PubMed ID: 7636529
[TBL] [Abstract][Full Text] [Related]
87. [The treatment of small cell lung cancer].
Li LY
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):443-6. PubMed ID: 1338986
[TBL] [Abstract][Full Text] [Related]
88. "Total" therapy for small cell carcinoma of the lung.
Johnson RE; Brereton HD; Kent CH
Ann Thorac Surg; 1978 Jun; 25(6):510-5. PubMed ID: 207232
[TBL] [Abstract][Full Text] [Related]
89. Late relapse of small cell lung cancer treated with radiation therapy alone--case report.
Saito Y; Hayakawa K; Mitsuhashi N; Nakajima N; Kato S; Nakazato Y; Niibe H
Lung Cancer; 1994 Mar; 10(5-6):319-24. PubMed ID: 8075974
[TBL] [Abstract][Full Text] [Related]
90. Long-term survival of a patient with small-cell lung cancer (SCLC) following treatment with thalidomide and combination chemotherapy.
Mall JW; Philipp AW; Mall W; Pollmann C
Angiogenesis; 2002; 5(1-2):11-3. PubMed ID: 12549855
[TBL] [Abstract][Full Text] [Related]
91. Improvement and plateau in survival of small-cell lung cancer since 1975: a population-based study.
Janssen-Heijnen ML; Schipper RM; Klinkhamer PJ; Crommelin MA; Coebergh JW
Ann Oncol; 1998 May; 9(5):543-7. PubMed ID: 9653496
[TBL] [Abstract][Full Text] [Related]
92. Causes of death in long-term survivors of non-small cell lung cancer: A regional Surveillance, Epidemiology, and End Results study.
Kanitkar AA; Schwartz AG; George J; Soubani AO
Ann Thorac Med; 2018; 13(2):76-81. PubMed ID: 29675057
[TBL] [Abstract][Full Text] [Related]
93. Early Deaths in Childhood Cancer in Romania-A Single Institution Study.
Pruteanu DP; Olteanu ED; Cosnarovici R; Mihut E; Ecea R; Todor N; Nagy V
Children (Basel); 2021 Sep; 8(9):. PubMed ID: 34572246
[TBL] [Abstract][Full Text] [Related]
94. Editorial on "Long-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is 'cured' from postoperative recurrence?".
Pfannschmidt J
J Thorac Dis; 2018 Feb; 10(2):610-613. PubMed ID: 29607121
[No Abstract] [Full Text] [Related]
95. 'Truly historic': How science helped kids win a landmark climate trial.
Marris E
Nature; 2023 Aug; 620(7975):710. PubMed ID: 37587286
[No Abstract] [Full Text] [Related]
96. Ten-year survival is not survivors at 10 years.
Bedeir K
Eur Heart J; 2022 Mar; 43(13):1360-1361. PubMed ID: 35137051
[No Abstract] [Full Text] [Related]
97. Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?
Plaja A; Moran T; Carcereny E; Saigi M; Hernández A; Cucurull M; Domènech M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948300
[TBL] [Abstract][Full Text] [Related]
98. Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period.
Asano F; Watanabe K; Shinkai M; Tei Y; Mishina K; Tanabe M; Ishii H; Shinoda M; Shimokawaji T; Kudo M; Kaneko T
Chin J Cancer; 2016 Jul; 35(1):63. PubMed ID: 27370896
[TBL] [Abstract][Full Text] [Related]
99. The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer.
Kwon SH; Hyun SH; Yoon JK; An YS; Oh YT; Choi JH; Park KJ; Lee SJ
Medicine (Baltimore); 2016 Feb; 95(5):e2772. PubMed ID: 26844524
[TBL] [Abstract][Full Text] [Related]
100. Small cell lung cancer survival: 3 years as a minimum for predicting a favorable outcome.
Lewiński T; Zuławski M
Lung Cancer; 2003 May; 40(2):203-13. PubMed ID: 12711123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
